IGC Pharma
(AMEX:IGC)IGC Pharma Stock (AMEX:IGC), Earnings Estimates, EPS, and Revenue
IGC Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 14
EPS
$-0.090
Quarterly Revenue
$204K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.2M
Analyze the earnings history of IGC Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/05/2024 | PM | IGC | Q4 | -$0.08 | — | — | — | $166.00K | — | — | — | Get Alert |
| 02/14/2024 | PM | IGC | Q3 | -$0.04 | — | -$0.09 | — | $332.00K | — | $204.00K | — | Get Alert |
| 11/13/2023 | AM | IGC | Q2 | -$0.05 | — | -$0.05 | — | $202.00K | — | $291.00K | — | Get Alert |
| 08/10/2023 | PM | IGC | Q1 | -$0.05 | — | -$0.04 | — | $212.00K | — | $555.00K | — | Get Alert |
| 07/07/2023 | PM | IGC | Q4 | -$0.12 | — | -$0.08 | — | $122.00K | — | $166.00K | — | Get Alert |
| 02/14/2023 | PM | IGC | Q3 | -$0.05 | — | -$0.04 | — | $142.00K | — | $332.00K | — | Get Alert |
| 11/01/2022 | PM | IGC | Q2 | -$0.09 | — | -$0.05 | — | $56.00K | — | $202.00K | — | Get Alert |
| 08/08/2022 | AM | IGC | Q1 | -$0.04 | — | -$0.05 | — | $77.00K | — | $212.00K | — | Get Alert |
| 06/22/2022 | PM | IGC | Q4 | -$0.07 | — | -$0.12 | — | $81.00K | — | $122.00K | — | Get Alert |
| 02/10/2022 | PM | IGC | Q3 | -$0.06 | — | -$0.05 | — | $108.00K | — | $142.00K | — | Get Alert |
| 10/29/2021 | PM | IGC | Q2 | $0.04 | — | -$0.09 | — | $125.00K | — | $56.00K | — | Get Alert |
| 08/11/2021 | PM | IGC | Q1 | -$0.05 | — | -$0.04 | — | $584.00K | — | $77.00K | — | Get Alert |
| 06/14/2021 | PM | IGC | Q4 | -$0.08 | — | -$0.07 | — | $29.00K | — | $81.00K | — | Get Alert |
| 02/13/2021 | PM | IGC | Q3 | -$0.04 | — | -$0.06 | — | $573.00K | — | $108.00K | — | Get Alert |
| 11/22/2020 | PM | IGC | Q2 | -$0.03 | — | $0.04 | — | $1.82M | — | $125.00K | — | Get Alert |
| 08/19/2020 | PM | IGC | Q1 | -$0.03 | — | -$0.05 | — | $1.65M | — | $584.00K | — | Get Alert |
| 07/13/2020 | PM | IGC | Q4 | -$0.06 | — | -$0.08 | — | $1.54M | — | $29.00K | — | Get Alert |
| 02/11/2020 | AM | IGC | Q3 | -$0.03 | — | -$0.04 | — | $1.28M | — | $573.00K | — | Get Alert |
| 11/06/2019 | AM | IGC | Q2 | -$0.03 | — | -$0.03 | — | $811.00K | — | $1.82M | — | Get Alert |
FAQ
When is IGC Pharma (AMEX:IGC) reporting earnings?
IGC Pharma (IGC) is scheduled to report earnings on July 5, 2024. The last reported earnings were for reported on February 14, 2024 for Q3.
What were the latest earnings per share (EPS) for IGC Pharma (AMEX:IGC)?
The Actual EPS was $-0.09, which missed the estimate of $0.00.
What were IGC Pharma’s (AMEX:IGC) revenues?
The Actual Revenue was $204K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.